Skip to main content

Table 1 Summary of the clinical features of the patients

From: Novel compound heterozygous variants in the RPL3L gene causing dilated cardiomyopathy type-2D: a case report and literature review

Clinical features

Our patient

Ganapathi et al.(2020)

Hemanth et al.(2021)

Bibhuti et al(2022).

Patient 1

Patient 2

Patient 3

Patient 4

Patient 5

Patient 6

Patient 7

Patient 8

Patient 9

Variants in RPL3L (NM_005061)

c.80G > A (p.Gly27Asp) and c.1074dupA (p.Ala359fs*6)

c.923 A > T (p.Asp308Val) and c.1027 C > T (p.Arg343Trp)

c.923 A > T (p.Asp308Val) and c.1027 C > T (p.Arg343Trp)

c.566 C > T (p.Thr189Met) and c.922G > A (p.Asp308Asn)

c.80G > A (p.Gly27Asp) and c.481 C > T (p.Arg161Trp)

c.80G > A (p.Gly27Asp) and c.481 C > T (p.Arg161Trp)

c.1076_1080delCCGTG

(p.Ala359Glyfs*4) and c.80G > A (p.Gly27Asp)

c.1076_1080delCCGTG

(p.Ala359Glyfs*4) and c.80G > A (p.Gly27Asp)

c.151 G > A (p.Ala51Thr)

and c.691G > T (p.Val231Phe)

Gender

Female

Female

Male

Male

Female

Male

Male

Male

Female

Age at Diagnosis

Of DCM

Day31

Day1

Day6

Day75

Day48

Day12

Day1

Day54

Day60

Country

China

Germany

Germany

Colombia

Spain

Spain

USA

USA

USA

Additional Cardiac Findings

PFO, PAC, TR, AB, MR and ST abnormalities,

PFO and PH

TR

TR, MR

RBBB

ST-T abnormalities

MR

ST and T

abnormalities

MR, TR.

ST and T abnormalities,

VSD

MR

ST and T abnormalities

MR

ST and T abnormalities

NA

Alive/Dead

Alive at 3 months

Died 21st

DOL

Died

15th

DOL

HT at 6 months

Alive at 9 years

HT at 5 months

Alive at

10 years

Died 30th DOL

Died 124th DOL

Died 56th DOL

HT at 2 months

Alive at 5 months

  1. The following abbreviations are used: DCM: dilated cardiomyopathy; PFO: patent foramen ovale; PAC: Premature atrial contractions, TR: tricuspid regurgitation; MR: mitral regurgitation; AB: atrioventricular block; ST: a segment in ECG from the beginning of S wave until the beginning of T wave; PH = pulmonary hypertension; RBBB: right bundle branch block; VSD:Ventricular septal defect; DOL: day of life; HT: heart transplantation